{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T07:57:03Z","timestamp":1794124623235,"version":"4.8.0"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi250398-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Respiratory viral infections (RVIs) are associated with elevated cardiovascular risk; however, less is known about cardiac complications after hospitalization for respiratory syncytial virus (RSV) vs other vaccine-preventable RVIs (COVID-19 or influenza).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250398-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare the risk of acute cardiovascular complications in adults hospitalized for RSV vs COVID-19 or influenza.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250398-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This population-based cross-sectional study, conducted before RSV vaccination rollout in Singapore, assessed all adults hospitalized for RSV or influenza (January 1, 2017, to June 30, 2024) and all adults hospitalized for COVID-19 during Omicron XBB\/JN.1 transmission (January 1, 2023, to June 30, 2024).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250398-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Hospitalization for RSV, influenza (vaccinated or unvaccinated), or COVID-19 (boosted [\u22653 vaccine doses] or unboosted [&amp;amp;lt;3 vaccine doses]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250398-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Cardiovascular events during RSV, influenza, or COVID-19 hospitalization, defined as any cardiac, cerebrovascular, or thrombotic event, occurring from admission until discharge or death. Odds of any cardiovascular event (RSV vs COVID-19 or RSV vs influenza) and severe RVI (intensive care unit admission) with or without an acute cardiovascular event were estimated using multivariate logistic regression, adjusted for sociodemographic and clinical characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250398-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 32\u202f960 RVI hospitalizations (mean [SD] patient age, 66.58 [18.99] years; 17\u202f056 [51.7%] female) were included (2148 for RSV, 14 389 for influenza, and 16 423 for COVID-19). Of the 2148 patients hospitalized for RSV, 234 (10.9%) had an acute cardiovascular event. Higher odds of any acute cardiovascular event (adjusted odds ratio [AOR], 1.31; 95% CI, 1.12-1.54) as well as other individual cardiac events were observed in RSV hospitalizations vs boosted COVID-19 (dysrhythmia: AOR, 1.52; 95% CI, 1.19-1.94; heart failure: AOR, 1.75; 95% CI, 1.30-2.35). Similarly, higher odds of any acute cardiovascular event (AOR, 1.58; 95% CI, 1.24-2.01) as well as dysrhythmias or heart failure were observed in patients hospitalized for RSV vs unboosted COVID-19. Odds of a cardiovascular event were not significantly different in RSV vs influenza, except among contemporaneous hospitalizations after the pandemic (2023-2024), where odds of heart failure (AOR, 2.09; 95% CI, 1.21-3.59) were significantly higher in RSV hospitalizations vs vaccine-breakthrough influenza hospitalizations. Occurrence of a cardiovascular event was associated with greater odds of severe RSV requiring intensive care unit admission (AOR, 2.36; 95% CI, 1.21-4.62).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250398-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cross-sectional study, 1 in 10 patients hospitalized for RSV had a concurrent acute cardiovascular event. Odds of cardiac events were significantly higher in RSV vs COVID-19 hospitalizations in both vaccine-boosted and unboosted individuals. In contemporaneous hospitalizations for RSV or influenza after the pandemic (2023-2024), odds of heart failure were significantly higher in RSV hospitalizations vs vaccine-breakthrough influenza hospitalizations. These findings suggest that patients with preexisting cardiovascular risk should consider vaccination against RVIs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.11764","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T11:31:20Z","timestamp":1747913480000},"page":"e2511764","source":"Crossref","is-referenced-by-count":28,"title":["Cardiac Events in Adults Hospitalized for Respiratory Syncytial Virus vs COVID-19 or Influenza"],"prefix":"10.1001","volume":"8","author":[{"given":"Liang En","family":"Wee","sequence":"first","affiliation":[{"name":"National Centre for Infectious Diseases, Singapore"},{"name":"Duke-NUS Graduate Medical School, National University of Singapore, Singapore"},{"name":"Department of Infectious Diseases, Singapore General Hospital, Singapore"},{"name":"Department of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue Tao","family":"Lim","sequence":"additional","affiliation":[{"name":"National Centre for Infectious Diseases, Singapore"},{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reen Wan Li","family":"Ho","sequence":"additional","affiliation":[{"name":"National Centre for Infectious Diseases, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin J.","family":"Chiew","sequence":"additional","affiliation":[{"name":"National Centre for Infectious Diseases, Singapore"},{"name":"Ministry of Health, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Chien Boon","family":"Lye","sequence":"additional","affiliation":[{"name":"National Centre for Infectious Diseases, Singapore"},{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore"},{"name":"Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore"},{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin Bryan","family":"Tan","sequence":"additional","affiliation":[{"name":"National Centre for Infectious Diseases, Singapore"},{"name":"Duke-NUS Graduate Medical School, National University of Singapore, Singapore"},{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore"},{"name":"Ministry of Health, Singapore"},{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"issue":"12","key":"zoi250398r1","doi-asserted-by":"publisher","first-page":"e773","DOI":"10.1016\/S2589-7500(21)00203-X","article-title":"Risk of acute respiratory infection and acute cardiovascular events following acute respiratory infection among adults with increased cardiovascular risk in England between 2008 and 2018: a retrospective, population-based cohort study.","volume":"3","author":"Davidson","year":"2021","journal-title":"Lancet Digit Health"},{"key":"zoi250398r2","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300361","author":"de Boer","year":"2024","journal-title":"NEJM Evid"},{"issue":"11","key":"zoi250398r3","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1093\/infdis\/jis597","article-title":"Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study.","volume":"206","author":"Warren-Gash","year":"2012","journal-title":"J Infect Dis"},{"key":"zoi250398r4","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(24)00255-8","author":"Wildenbeest","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"14","key":"zoi250398r5","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.jacc.2018.02.013","article-title":"Respiratory syncytial virus and associations with cardiovascular disease in adults.","volume":"71","author":"Ivey","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"zoi250398r6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.diagmicrobio.2016.02.025","article-title":"Morbidity and mortality among patients with respiratory syncytial virus infection: a 2-year retrospective review.","volume":"85","author":"Anderson","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"zoi250398r7","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jamainternmed.2024.0212","article-title":"Acute cardiac events in hospitalized older adults with respiratory syncytial virus infection.","volume":"184","author":"Woodruff","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"7","key":"zoi250398r8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/eurjpc\/zwae016","article-title":"Association of respiratory infections and the impact of vaccinations on cardiovascular diseases.","volume":"31","author":"Rademacher","year":"2024","journal-title":"Eur J Prev Cardiol"},{"issue":"7","key":"zoi250398r9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults.","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med"},{"issue":"24","key":"zoi250398r10","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-based RSV preF vaccine in older adults.","volume":"389","author":"Wilson","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi250398r11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1136\/thoraxjnl-2021-216949","article-title":"Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.","volume":"77","author":"Hedberg","year":"2022","journal-title":"Thorax"},{"issue":"8","key":"zoi250398r12","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/cid\/cit471","article-title":"High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections.","volume":"57","author":"Lee","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"4","key":"zoi250398r13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cmi.2016.11.014","article-title":"Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France.","volume":"23","author":"Loubet","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"zoi250398r14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/irv.12730","article-title":"Characterisation of respiratory syncytial virus activity in children and adults presenting with acute respiratory illness at primary care clinics in Singapore, 2014-2018.","volume":"14","author":"Ang","year":"2020","journal-title":"Influenza Other Respir Viruses"},{"issue":"11","key":"zoi250398r15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.47102\/annals-acadmedsg.V47N11p445","article-title":"Survey of respiratory virus in patients hospitalised for acute exacerbations of heart failure - a prospective observational study.","volume":"47","author":"Chan","year":"2018","journal-title":"Ann Acad Med Singap"},{"issue":"11","key":"zoi250398r16","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.cmi.2020.06.027","article-title":"Reduction in healthcare-associated respiratory viral infections during a COVID-19 outbreak.","volume":"26","author":"Wee","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"zoi250398r17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.12968\/bjcn.2018.23.6.244","article-title":"Maximising influenza vaccination awareness and uptake among older adults in Singapore.","volume":"23","author":"Rusli","year":"2018","journal-title":"Br J Community Nurs"},{"issue":"8","key":"zoi250398r18","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/cid\/ciad345","article-title":"Long-term real-world protection afforded by third mRNA doses against symptomatic severe acute respiratory syndrome coronavirus 2 infections, coronavirus disease 19-related emergency attendances and hospitalizations amongst older Singaporeans during an Omicron XBB wave.","volume":"77","author":"Wee","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"5","key":"zoi250398r19","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/cid\/ciae339","article-title":"Risks of SARS-CoV-2 JN.1 infection and COVID-19 associated emergency-department (ED) visits\/hospitalizations following updated boosters and prior infection: a population-based cohort study.","volume":"79","author":"Chong","year":"2024","journal-title":"Clin Infect Dis"},{"key":"zoi250398r20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.puhe.2024.05.003","article-title":"Access to COVID-19 vaccination by socio-economic status in older Singaporean adults: a population-based cohort study.","volume":"233","author":"Wee","year":"2024","journal-title":"Public Health"},{"issue":"1","key":"zoi250398r21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244746","article-title":"Validating International Classification of Disease 10th Revision algorithms for identifying influenza and respiratory syncytial virus hospitalizations.","volume":"16","author":"Hamilton","year":"2021","journal-title":"PLoS One"},{"key":"zoi250398r22","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2025.101494","article-title":"Severity of respiratory syncytial virus versus SARS-CoV-2 Omicron and influenza infection amongst hospitalized Singaporean adults: a national cohort study.","volume":"55","author":"Wee","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"issue":"26","key":"zoi250398r23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126356","article-title":"Risk of death and cardiovascular events following COVID-19 vaccination or positive SARS-CoV-2 test amongst adult Singaporeans during Omicron transmission.","volume":"42","author":"Wee","year":"2024","journal-title":"Vaccine"},{"issue":"1","key":"zoi250398r24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/cid\/ciad469","article-title":"Long-term cardiovascular, cerebrovascular, and other thrombotic complications in COVID-19 survivors: a retrospective cohort study.","volume":"78","author":"Lim","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"19","key":"zoi250398r25","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/sim.5753","article-title":"A tutorial on propensity score estimation for multiple treatments using generalized boosted models.","volume":"32","author":"McCaffrey","year":"2013","journal-title":"Stat Med"},{"issue":"6","key":"zoi250398r26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jacc.2022.11.044","article-title":"Acute cardiac events during COVID-19-associated hospitalizations.","volume":"81","author":"Woodruff","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"zoi250398r27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.4954","article-title":"Severity of respiratory syncytial virus vs COVID-19 and influenza among hospitalized US adults.","volume":"7","author":"Surie","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi250398r28","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.vaccine.2023.12.050","article-title":"Covid-19 and influenza vaccine effectiveness against associated hospital admission and death among individuals over 65 years in Norway: a population-based cohort study, 3 October 2022 to 20 June 2023.","volume":"42","author":"Sepp\u00e4l\u00e4","year":"2024","journal-title":"Vaccine"},{"issue":"7","key":"zoi250398r29","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/j.1651-2227.2004.tb02685.x","article-title":"Cardiac troponin T levels and myocardial involvement in children with severe respiratory syncytial virus lung disease.","volume":"93","author":"Eisenhut","year":"2004","journal-title":"Acta Paediatr"},{"key":"zoi250398r30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/1471-2334-10-305","article-title":"Altered cardiac rhythm in infants with bronchiolitis and respiratory syncytial virus infection.","volume":"10","author":"Esposito","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"4","key":"zoi250398r31","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1186\/cc4984","article-title":"Extrapulmonary manifestations of severe respiratory syncytial virus infection\u2013a systematic review.","volume":"10","author":"Eisenhut","year":"2006","journal-title":"Crit Care"},{"issue":"10","key":"zoi250398r32","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.cmi.2024.06.011","article-title":"Long-term cardiovascular, cerebrovascular, and thrombotic complications after SARS-CoV-2-Omicron infection: a retrospective cohort study.","volume":"30","author":"Wee","year":"2024","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"zoi250398r33","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cmi.2023.12.019","article-title":"Long-term neuropsychiatric sequelae of Delta versus Omicron SARS-CoV-2 infection.","volume":"30","author":"Wee","year":"2024","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"zoi250398r34","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1093\/infdis\/jiad559","article-title":"The annual economic burden of respiratory syncytial virus in adults in the United States.","volume":"230","author":"Carrico","year":"2024","journal-title":"J Infect Dis"},{"key":"zoi250398r35","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2023.100919","article-title":"Factors associated with delayed diagnosis of symptomatic adult COVID-19 cases presenting to primary care: a population-wide study during transition from Delta to Omicron BA.1 in Singapore.","volume":"41","author":"Tan","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"issue":"2","key":"zoi250398r36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.47102\/annals-acadmedsg.2023297","article-title":"Oral antiviral utilisation among older adults with COVID-19 in primary care: a population-wide study during successive Omicron waves in Singapore.","volume":"53","author":"Tan","year":"2024","journal-title":"Ann Acad Med Singap"},{"issue":"10","key":"zoi250398r37","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.cmi.2023.06.016","article-title":"Real-world effectiveness of nirmatrelvir\/ritonavir against COVID-19 hospitalizations and severe COVID-19 in community-dwelling elderly Singaporeans during Omicron BA.2, BA.4\/5, and XBB transmission.","volume":"29","author":"Wee","year":"2023","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"zoi250398r38","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/cid\/ciad679","article-title":"Influenza vaccine effectiveness pre-pandemic among adults hospitalized with congestive heart failure or chronic obstructive pulmonary disease and older adults.","volume":"78","author":"Tippett","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi250398r39","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ejhf.3469","article-title":"Effect of seasonal influenza and COVID-19 vaccination on severity and long-term outcomes of patients with heart failure decompensations.","volume":"27","author":"Mir\u00f3","year":"2025","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"zoi250398r40","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1093\/cid\/ciad031","article-title":"Prevalence and clinical outcomes of respiratory syncytial virus vs influenza in adults hospitalized with acute respiratory illness from a prospective multicenter study.","volume":"76","author":"Begley","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"12","key":"zoi250398r41","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1016\/j.vaccine.2024.03.060","article-title":"The early safety profile of simultaneous vaccination against influenza and respiratory syncytial virus (RSV) in patients with high-risk heart failure.","volume":"42","author":"Biegus","year":"2024","journal-title":"Vaccine"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2834362\/wee_2025_oi_250398_1747250688.69915.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T11:31:20Z","timestamp":1747913480000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2834362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.11764","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]}}}